Document is current
Any future updates will be listed below
-
Authors
Anada, Masahide https://orcid.org/0009-0007-3470-9308
Fujita, Haruyuki
Ishikawa, Ryou
Takahashi, Shigeo
Yoshida, Syunsuke
Nishide, Takamasa
Kinoshita, Toshifumi
Kadowaki, Norimitsu
Shibata, Toru
- License Information
-
More Information
Article History
Received: 8 August 2024
Accepted: 15 September 2024
First Online: 27 September 2024
Declarations
:
: The authors declare that they have no conflict of interest.
: All procedures involving human participants performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Research Ethics Committee of Kagawa University Faculty of Medicine (Kagawa, Japan) approved the present case report (approval no. 2022–210). The use of nivolumab in this patient was approved by the institutional review board of Kagawa University Hospital.
: Written informed consent was obtained from the patient.
: Not applicable.
